Cagrilintide
RENEW 1
Novo Nordisk · Phase 3 · Active, not recruiting · Enrollment 300
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Cagrilintide
Novo Nordisk · Phase 3 · Active, not recruiting · Enrollment 300
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.